Humacyte, Inc. (HUMA) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Humacyte, Inc. (HUMA)
Company Research
Source: Seeking Alpha
Laura Niklason - Founder, President, CEO & Director Dale Sander - CFO, Chief Corporate Development Officer & Treasurer Conference Call Participants Thomas Johnson - Lifesci Advisors, LLC Sneha Muthe - Barclays Bank PLC, Research Division Iseult McMahon - BTIG, LLC, Research Division Joshua Jennings - TD Cowen, Research Division Jason Kolbert - D. Boral Capital LLC, Research Division Bruce Jackson - The Benchmark Company, LLC, Research Division Swayampakula Ramakanth - H.C. Wainwright & Co, LLC, Research Division Presentation Operator Good morning, ladies and gentlemen, and welcome to the Humacyte's Third Quarter Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. I'll now turn the call over to Tom Johnson with LifeSci Advisors. Please go ahead. Thomas Johnson Lifesci Advisors, LLC Thank you, operator. Before we proceed with the call, I would like to remind everyone that certain statements made during
Show less
Read more
Impact Snapshot
Event Time:
HUMA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HUMA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HUMA alerts
High impacting Humacyte, Inc. news events
Weekly update
A roundup of the hottest topics
HUMA
News
- Humacyte Announces Hospital Charge Data Showing High Expense of Preventable Extremity Arterial Injury ComplicationsGlobeNewswire
- Is Humacyte, Inc. (HUMA) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]Yahoo! Finance
- Humacyte (NASDAQ:HUMA) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $25.00 price target on the stock.MarketBeat
- Humacyte Announces Planned Marketing Authorization Application for Symvess® in Israel [Yahoo! Finance]Yahoo! Finance
- Humacyte Announces Planned Marketing Authorization Application for Symvess® in IsraelGlobeNewswire
HUMA
Earnings
- 11/12/25 - Beat
HUMA
Sec Filings
- 1/9/26 - Form SCHEDULE
- 12/16/25 - Form 8-K
- 12/16/25 - Form 424B5
- HUMA's page on the SEC website